HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

glycylphenylalanine

RN given refers to (DL)-isomer
Also Known As:
Gly-Phe; gly-D-phenylalanine; gly-L-phenylalanine; glycyl-D-phenylalanine; glycyl-L-phenylalanine; glycylphenylalanine monobrosylate, (L)-isomer; glycylphenylalanine monohydrochloride, monohydrate, (L)-isomer; glycylphenylalanine monotosylate, (L)-isomer; glycylphenylalanine, (D)-isomer; glycylphenylalanine, (L)-isomer
Networked: 23 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ganesan, Sundar: 1 article (01/2022)
2. Heijjer, Christopher N: 1 article (01/2022)
3. Hwang, Il-Young: 1 article (01/2022)
4. Karlsson, Mikael C I: 1 article (01/2022)
5. Kehrl, John H: 1 article (01/2022)
6. Nabar, Neel R: 1 article (01/2022)
7. Shi, Chong-Shan: 1 article (01/2022)
8. Campagno, Keith E: 1 article (01/2018)
9. Fliesler, Steven J: 1 article (01/2018)
10. Grishchuk, Yulia: 1 article (01/2018)

Related Diseases

1. Rupture
2. Neoplasms (Cancer)
02/01/1999 - "The results indicate that the PHEG-Gly-Phe-Ala-Leu-PDM conjugate is a promising candidate for cancer treatment."
07/01/2012 - "We have studied anti-tumor properties of bone marrow derived peptide Phe-Leu-Gly-Phe-Pro-Thr (MP-1) synthesized by classical methods. "
10/15/2012 - "The purpose of this study was to use a near-infrared (NIR) fluorescent cyclic His-Try-Gly-Phe peptide to characterize and image the expressions of matrix metalloproteinases (MMPs), which are correlated with cancer promotion, in an inflammation-induced colorectal cancer (ICRC) model. "
01/01/1989 - "4-methoxy-beta-naphthylamide and 7-amino-4-methyl coumarin, derivatives of Z-Ala-Arg-Arg, Leu- and Gly-Phe-beta-naphthylamides were used as substrates in estimation of peptide hydrolases activity in blood serum of patients with malignant tumors and glomerulonephritis in order to ascertain their efficiency for diagnostic purposes in clinic. "
11/01/1999 - "Phe-Leu-Gly-Phe-Pro-Thr (MP-1) manifests an immunocorrecting effect by restoring the level of antibody production in animals suffering from immunodeficiencies of various etiologies; Leu-Val-Val-Tyr-Pro-Trp (MP-2) manifests an antitumor effect by abolishing the inhibitory action of tumor cells on the functional activity of T-lymphocytes; Leu-Val-Cys-Tyr-Pro-Gln (MP-3) stimulates phagocytosis by macrophages and, in this way, protects animals from infections caused by pathogenic microorganisms; and Phe-Pro-Arg-Ile-Met-Thr-Pro (MP-4) is a new factor of cell differentiation inducing terminal cell differentiation in the HL-60 and K-562 leukemic cell lines."
3. Inflammation (Inflammations)
4. Colorectal Neoplasms (Colorectal Cancer)
5. Exocrine Pancreatic Insufficiency

Related Drugs and Biologics

1. Thapsigargin
2. Calcium
3. Phenylalanine (L-Phenylalanine)
4. Peptides (Polypeptides)
5. Dipeptides
6. Neutral Amino Acids
7. Matrix Metalloproteinases (MMPs)
8. Lysine (L-Lysine)
9. Glycine (Aminoacetic Acid)
10. Amino Acids

Related Therapies and Procedures

1. Ligation
2. Analgesia